蓝盾光电8000万元收购终止！苏州富豪家族掌舵，实控人今年套现超1500万元

Core Viewpoint - The company, Blue Shield Optoelectronics, has decided to terminate the equity transfer agreement with Zhuhai Luoheng regarding Shanghai Xingsi Semiconductor, aiming to control investments and protect the interests of shareholders, especially minority shareholders [1][3]. Group 1: Company Background - Blue Shield Optoelectronics was listed on the Growth Enterprise Market in August 2020, focusing on high-end analytical measurement instruments for environmental monitoring and meteorological observation [3]. - Shanghai Xingsi Semiconductor, established in 2020, develops chips primarily for applications in 5G CPE, satellite smartphones, low-orbit satellite communication terminals, and satellite IoT terminals, indicating a weak correlation with Blue Shield's main business [3]. Group 2: Investment Details - In December 2023, Blue Shield announced an investment of 180 million yuan to acquire approximately 5% equity in Shanghai Xingsi, with a post-investment valuation of 3.6 billion yuan, reflecting a significant appreciation rate of 5142.86% [3]. - The investment attracted attention from the Shenzhen Stock Exchange due to the high premium and the ongoing losses of Shanghai Xingsi, which exceeded 800 million yuan over 2022 and the first three quarters of 2023 [3]. Group 3: Shareholder Actions - The controlling shareholder, Yuan Yonggang, and associated parties have engaged in multiple share reductions, including a 221 million yuan cash-out through a share transfer at 33.55 yuan per share, representing 5% of the total share capital [4]. - Following a series of planned reductions, the company announced a termination of the reduction plan, committing not to reduce shares for six months [4][6]. Group 4: Financial Performance - For the first three quarters of the current year, Blue Shield reported total revenue of 272 million yuan, a year-on-year decline of 21.33%, and a net loss attributable to shareholders of 59.02 million yuan, a staggering drop of 827.61% [9]. - The company's stock price has seen fluctuations, with a nearly 30% increase from July 26, 2024, to February 20, 2025, despite the ongoing operational challenges [6][9].